<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0027831" disease_type="Neoplastic Process" abbrv="">Recklinghausen's disease</z:e> is considered to be the <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder with the highest rate of mutation after <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is a neuroectodermal disorder with considerable clinical effects </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: We present a study of 14 patients seen for <z:e sem="disease" ids="C0221263" disease_type="Disease or Syndrome" abbrv="">caf√©-au-lait spots</z:e> in the Clinical Genetics Department of the Hospital Infantil Sur </plain></SENT>
<SENT sid="3" pm="."><plain>A detailed questionnaire and physical examination was done to obtain a clinical outline </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Suspicion of this condition, together with laboratory investigations led to the conclusion that the cases were <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> </plain></SENT>
</text></document>